The impact of genomics on anti-infectives drug discovery and development
- 1 October 2002
- journal article
- review article
- Published by Elsevier in Trends in Microbiology
- Vol. 10 (10) , s22-s26
- https://doi.org/10.1016/s0966-842x(02)02427-7
Abstract
No abstract availableKeywords
This publication has 30 references indexed in Scilit:
- Individual acid aspartic proteinases (Saps) 1-6 of Candida albicans are not essential for invasion and colonization of the gastrointestinal tract in miceMicrobial Pathogenesis, 2002
- Use of signature-tagged mutagenesis in pathogenesis studiesCurrent Opinion in Microbiology, 2002
- Virogenomics: a novel approach to antiviral drug discoveryDrug Discovery Today, 2001
- Comparing Genomes within the Species Mycobacterium tuberculosisGenome Research, 2001
- Helicobacter pylori strain-specific differences in genetic content, identified by microarray, influence host inflammatory responsesJournal of Clinical Investigation, 2001
- Signature‐tagged and directed mutagenesis identify PABA synthetase as essential for Aspergillus fumigatus pathogenicityMolecular Microbiology, 2000
- Genome-Wide Expression Patterns in Saccharomyces cerevisiae : Comparison of Drug Treatments and Genetic Alterations Affecting Biosynthesis of ErgosterolAntimicrobial Agents and Chemotherapy, 2000
- [5] IVET and RIVET: Use of gene fusions to identify bacterial virulence factors specifically induced in host tissuesPublished by Elsevier ,2000
- Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridizationProceedings of the National Academy of Sciences, 1999
- In Vivo Genetic Analysis of Bacterial VirulenceAnnual Review of Microbiology, 1999